Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
568 RUIN CREEK RD
STE 128
Henderson, NC 27536
Summary
- Dr. Manesh Patel is the Chief, Division of Cardiology at Duke University in Durham, NC and is affiliated with multiple hospitals in the area, including Duke Raleigh Hospital, Central Carolina Hospital, Duke Regional Hospital, and Duke University Hospital. He received his medical degree from Emory University School of Medicine and has been in practice 20 years. He specializes in and interventional cardiology and is experienced in valvular heart disease, interventional cardiology, cardiac catheterization, and peripheral arterial disease.
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 2002 - 2006
- Duke Univ Med Ctr2001 - 2001
- Duke University HospitalResidency, Internal Medicine, 1998 - 2000
- Duke University HospitalInternship, Internal Medicine, 1997 - 1998
- Emory University School of MedicineClass of 1997
Certifications & Licensure
- NC State Medical License 1997 - 2025
- VA State Medical License 2002 - 2006
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Distinguished Richard Stack Professor of Cardiology Duke University, 2020
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- PROspective Multicenter Imaging Study for Evaluation of Chest Pain Start of enrollment: 2010 Jul 01
- Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE) Start of enrollment: 2013 Sep 26
- Coronary Orbital Atherectomy System Study Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Random Survival Forest Machine Learning for the Prediction of Cardiovascular Events Among Patients With a Measured Lipoprotein(a) Level: A Model Development Study.Jay B Lusk, Emily C O'Brien, Bradley G Hammill, Fan Li, Brian Mac Grory
Circulation. Genomic and Precision Medicine. 2025-02-01 - Economic Outcomes With Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results From the PRECISE Randomized Trial.Derek S Chew, Daniel B Mark, Yanhong Li, Michael G Nanna, Michelle D Kelsey
Circulation. Cardiovascular Quality and Outcomes. 2025-02-01 - Quality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE...Daniel B Mark, Yanhong Li, Michael G Nanna, Michelle D Kelsey, Melanie R Daniels
Circulation. Cardiovascular Quality and Outcomes. 2025-02-01
Journal Articles
- Rivaroxaban versus warfarin in non-valvular atrial fibrillationPatel, MR, Mahaffey, KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JP, Berkowitz SD, Fox KAA, ..., N Engl J Med, 8/10/2011
- Potential Association of the ISCHEMIA Trial with the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart DiseaseJohn A Spertus, Manesh R Patel, JAMA Internal Medicine
- Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical RevascularizationKenneth Mahaffey, Manesh R Patel, W Schuyler Jones, William R Hiatt, Jeffrey S Berger, ScienceDirect
- Join now to see all
Authored Content
- ACC Appropriate Use Criteria Methodology: 2018 Update A Report of the American College of Cardiology Appropriate Use Criteria Task ForceFebruary 2018
- Antithrombotic Therapy in Peripheral Artery Disease Generating and Translating Evidence into PracticeJanuary 2018
Press Mentions
- Why 'Cough CPR' Is Not the Lifesaver It's Made Out to BeJanuary 22nd, 2025
- What Now for Factor XI Inhibitors in AF?December 11th, 2024
- For AF, LAA Rivals Anticoagulants After AblationNovember 20th, 2024
- Join now to see all
Committees
- Chair, ACC Appropriate Use Criteria 2014 - 2016
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: